Cardiac patch in clinical trial: dose finding completed
The world’s only clinical trial in which patients with heart failure are implanted with artificial heart tissue to permanently strengthen the heart muscle has reached its first important milestone: the determination of the maximum safe dose was completed after treatment of 10 patients. The BioVAT-HF-DZHK20 study is conducted at the




